Fundz
Real-time · AI · Cross-signal

Debbie Chirnomas just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Debbie Chirnomas's next role move, new team, and the deals that follow. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo

Everyone else gives you a piece

✕Crunchbase & PitchBook list the company — No person, no timing, no opener.
✕ZoomInfo & Apollo sell you a contact — No trigger, no reason to reach out now.
✕LinkedIn Sales Navigator shows you people — No real-time signal, no opener.
✕Clay enriches lists you built — No live signal of its own, no who or when.
✕ChatGPT & gen-AI tools answer on a delay — No live data, no verified contact.
Who to contactWhat to sayWhen to reach outWhy now

Only Fundz delivers all four.

Watching Faeth Therapeutics? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan

Faeth Therapeutics Appoints Debbie Chirnomas, M.D., M.P.H., As Chief Medical Officer Benzinga

PRIVATESep 29, 2023•over 2 years ago

Position

Chief Medical Officer

Company

Faeth Therapeutics

Debbie Chirnomas
San Francisco

Description

Faeth Therapeutics , a clinical-stage biotechnology company targeting cancer metabolism, today announced the appointment of Debbie Chirnomas M.D., M.P.H., as Chief Medical Officer. Dr. Chirnomas will head up the early and late-stage clinical development for Faeth's oncology pipeline.

Company Information

Company

Faeth Therapeutics

Location

San Francisco, California, United States

About

Everything needs food to survive and grow, including cancer. There is an entire dimension of human biology in metabolism that’s been too complex to leverage in the fight against cancer––until now.

Predictive Intelligence
Strategic

ML-powered predictions for Faeth Therapeutics's next move

Learn about Strategic plan

Related People

Suggested for you

Choose your plan to reveal verified contacts

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies.